ExpreS2ion publishes video presentation
Hørsholm, Denmark, 05 September 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed company presentation by CEO Bent U. Frandsen in which he presents an update on development of ExpreS2ion’s business model, pipeline assets, recent developments, TO 8 warrant program and advancement towards key catalysts is now available on the company’s website.In the presentation, Frandsen emphasized the importance of the clinical proof-of-concept and Phase III validation of the Company’s ExpreS2[TM] technology within the Bavarian Nordic